(PharmaNewsWire.Com, October 11, 2019 ) The global Asia and North Africa Hemodialysis & Peritoneal Dialysis market is segmented on the basis of product, services and region. The rising prevalence of end-stage renal disease (ESRD), diabetes, and hypertension is stimulating the demand for dialysis treatment in the emerging nations.
The dialysis market in emerging nations is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis. The hemodialysis market is segmented into products and services. Hemodialysis products include hemodialysis machines and hemodialysis consumables/supplies, whereas hemodialysis services are classified into in-center services and home services. The peritoneal dialysis market, segmented into products and services, includes peritoneal dialysis machines, concentrates/dialysates, catheters, transfer sets, and other consumables such as tubing sets, drain bags, disconnect caps, bag connections, catheter stabilizing devices, and ports.
On the basis of region, the dialysis market in emerging nations is segmented into India, Asia (excluding India), and the MENA region. The market in Asia is expected to grow at a higher rate during the forecast period (2015-2020). This high growth is predominantly driven by the growing number of dialysis centers, low preference for kidney transplantation, rising awareness about renal diseases, development of low-cost products, and increasing focus of dialysis firms on the Asian market. The Indian dialysis market is expected to witness a lucrative CAGR during the forecast period due to the growing patient base, government focus on providing low-cost dialysis treatment and promoting the indigenous manufacturing of dialysis products, and the growing adoption of home dialysis treatment in the country.
A majority of the leading market players adopted growth strategies such as geographical expansions and mergers & acquisitions to increase their presence in the dialysis market in the emerging nations. Leading market players are also focusing on strategic contracts & partnerships to gain larger market shares. Through these strategies, companies are focusing on strengthening their product offerings, catering to specific consumer demands, and expanding their footprints in the emerging markets.
The major players operating in this market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), and Nikkiso Co. Ltd. (Japan).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
